MedPath

RESURGE THERAPEUTICS INC.

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)β€’ Click on a phase to view related trials

Phase 1
1 (100.0%)

RT-310 Dose Escalation BPH Study

Phase 1
Recruiting
Conditions
BPH (Benign Prostatic Hyperplasia)
Lower Urinary Tract Symptoms
First Posted Date
2023-11-18
Last Posted Date
2025-07-29
Lead Sponsor
Resurge Therapeutics Inc.
Target Recruit Count
20
Registration Number
NCT06136819
Locations
πŸ‡¦πŸ‡Ί

Australian Clinical Trials, Wahroonga, New South Wales, Australia

πŸ‡¦πŸ‡Ί

Goldfields Urology, Bendigo, Victoria, Australia

πŸ‡¦πŸ‡Ί

Western Urology, Maribyrnong, Victoria, Australia

and more 1 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.